
Related news and events
Cooley Secures Decisive Victory on Behalf of Horizon Therapeutics in Connection With Its $27.8 Billion Acquisition by Amgen
Experience
Poppi Announces $1.95 Billion Sale to PepsiCo
March 17, 2025
Cooley advised VNGR Beverage (doing business as poppi), a fast-growing prebiotic soda brand, on its acquisition by PepsiCo (Nasdaq: PEP) for $1.95 billion, including an additional potential earnout consideration subject to the achievement of certain performance milestones within a specified period after closing.
Related contacts
Related Practices & Industries
Araris Biotech’s up to $1.14 Billion Acquisition by Taiho Pharmaceutical
March 17, 2025
Cooley advised Araris Biotech, a Swiss biotechnology company developing next-generation antibody-drug conjugates, on its definitive agreement to be acquired by Japan-based Taiho Pharmaceutical for up to $1.14 billion in cash.
Related contacts
Related Practices & Industries
DataStax Announces Acquisition by IBM
February 25, 2025
Cooley advised DataStax, an artificial intelligence (AI) and data solution provider, on its acquisition by IBM (NYSE: IBM), a provider of global hybrid cloud and AI solutions and consulting expertise.
Related contacts
Related Practices & Industries
AGS Announces Definitive Agreement to Be Acquired by Brightstar Capital Partners for $1.1 Billion
May 9, 2024
Cooley advised PlayAGS, a global gaming supplier of high-performing slots, tables and interactive products, on its definitive agreement to be acquired by the affiliates of Brightstar Capital Partners for $1.1 billion.
Related contacts
Related Practices & Industries
Freshworks Agrees to Acquire Device42
May 3, 2024
Cooley advised Freshworks (Nasdaq: FRSH), a company that creates artificial intelligence-boosted business software for IT, customer support, sales, and marketing teams to make them more efficient and deliver more value for immediate business impact, on its agreement and plan of merger with D42 Parent (Device42), pursuant to which Freshworks – through its wholly owned subsidiary, Doppler Merger Sub –will acquire all of the outstanding equity interests of Device42 for an aggregate purchase price of approximately $230 million.Cooley advised Freshworks (Nasdaq: FRSH), a company that creates artificial intelligence-boosted business software for IT, customer support, sales, and marketing teams to make them more efficient and deliver more value for immediate business impact, on its agreement and plan of merger with D42 Parent (Device42), pursuant to which Freshworks – through its wholly owned subsidiary, Doppler Merger Sub –will acquire all of the outstanding equity interests of Device42 for an aggregate purchase price of approximately $230 million.
Related contacts
Related Practices & Industries
Admissions and credentials
Admitted to practice in Washington, DC only
Not admitted to practice in Massachusetts